Medicare Compliance & Reimbursement
Avoid 90662 for Patients Under 65
Question: We reported 90662 for a patient’s Fluzone shot and it was denied. The insurer said the patient doesn’t meet the age requirements, but we didn’t see any age listed on the code descriptor. Can you advise?
Answer: Most MACs will only cover 90662 (Influenza virus vaccine, split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use) for patients age 65 and older. The higher antigen content offers increased protection to older patients, and this code is considered a high dosage of the Fluzone vaccine because it contains four times the hemagglutinin antigen per influenza strain than traditional influenza vaccines.
The vaccine may also be appropriate for people with impaired immune responsiveness, who may benefit from an increased antigen dose to more effectively stimulate the needed immune response. If that is the case with your patient and the insurer denied it, have the physician write an appeal letter to the payer explaining the unique circumstances under which he administered the Fluzone shot and why the high dose was required for your particular patient.
If your patient was under age 65 and was not immunocompromised, you should not report 90662 for Fluzone. In healthy, younger patients, the doctor would typically administer only a standard dosage of the drug, which you would report with 90658 (Influenza virus vaccine, trivalent, split virus, when administered to individuals 3 years of age and older, for intramuscular use) instead of 90662.
Medicare Compliance & Reimbursement
- Outpatient Outlook:
Tune In to Key Changes Listed in 2015 Medicare Physician Fee Schedule
Chronic care management gains big victory in new, reimbursable CPT code. Get ready for both [...] - Post-Acute Care:
4 Major Perks of a New PAC Patient Assessment Tool
IMPACT Act paves the road for new and improved discharge methods. Change isn’t a walk [...] - Audits and Records:
Are You Among the Providers Who Can't Produce Documentation?
Take note of the four-pronged approach used by CERT reviewers. You don’t want to cause [...] - Interpreter Services:
Provide Interpreter Services Without Hurting Your Bottom Line
Clear confusion surrounding these services. Providing services to patients who have limited abilities to communicate [...] - Reader Question:
Avoid 90662 for Patients Under 65
Question: We reported 90662 for a patient’s Fluzone shot and it was denied. The insurer said [...] - HIPAA:
Use OCR Guidance to Update Privacy Policies
The Windsor decision has effectively changed the meaning of three key terms. Federal law cannot [...] - Industry Notes:
CMS: Submit Requested Documentation within 45 Days,or Face Denials
If your payer is performing a pre-payment audit of your claims, the MAC will typically [...]
